What is Seaport Res Ptn’s Estimate for Innospec Q1 Earnings?

Innospec Inc. (NASDAQ:IOSP) – Seaport Res Ptn increased their Q1 2025 earnings per share (EPS) estimates for Innospec in a report released on Monday, April 21st. Seaport Res Ptn analyst M. Harrison now anticipates that the specialty chemicals company will post earnings of $1.39 per share for the quarter, up from their previous forecast of $1.38. Seaport Res Ptn currently has a “Strong-Buy” rating on the stock. The consensus estimate for Innospec’s current full-year earnings is $6.18 per share.

Innospec (NASDAQ:IOSP) last announced its earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.05. The business had revenue of $466.80 million for the quarter, compared to analysts’ expectations of $447.43 million. Innospec had a return on equity of 12.27% and a net margin of 1.93%.

Separately, StockNews.com cut shares of Innospec from a “buy” rating to a “hold” rating in a report on Wednesday, April 2nd.

Innospec Price Performance

Shares of IOSP stock opened at $88.39 on Wednesday. The stock’s 50-day moving average is $95.37 and its 200 day moving average is $107.32. Innospec has a 1-year low of $80.32 and a 1-year high of $133.71. The company has a market cap of $2.22 billion, a P/E ratio of 62.25 and a beta of 1.03.

Institutional Investors Weigh In On Innospec

Large investors have recently made changes to their positions in the stock. Barclays PLC raised its stake in Innospec by 357.1% in the 3rd quarter. Barclays PLC now owns 44,559 shares of the specialty chemicals company’s stock worth $5,039,000 after acquiring an additional 34,811 shares during the last quarter. Sanctuary Advisors LLC raised its stake in shares of Innospec by 63.6% in the third quarter. Sanctuary Advisors LLC now owns 3,152 shares of the specialty chemicals company’s stock worth $377,000 after purchasing an additional 1,225 shares during the last quarter. Franklin Resources Inc. lifted its stake in Innospec by 8.6% during the 3rd quarter. Franklin Resources Inc. now owns 27,282 shares of the specialty chemicals company’s stock valued at $3,116,000 after acquiring an additional 2,154 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Innospec by 24.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 266,688 shares of the specialty chemicals company’s stock valued at $30,160,000 after acquiring an additional 52,640 shares during the last quarter. Finally, Diversified Trust Co increased its stake in shares of Innospec by 9.5% in the fourth quarter. Diversified Trust Co now owns 3,543 shares of the specialty chemicals company’s stock worth $390,000 after acquiring an additional 306 shares during the period. 96.64% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Innospec

In other Innospec news, VP Philip John Boon sold 3,754 shares of the firm’s stock in a transaction dated Friday, February 21st. The stock was sold at an average price of $103.30, for a total value of $387,788.20. Following the completion of the sale, the vice president now owns 20,079 shares of the company’s stock, valued at approximately $2,074,160.70. This trade represents a 15.75 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Corbin Barnes sold 2,692 shares of the stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $103.30, for a total transaction of $278,083.60. Following the completion of the transaction, the senior vice president now directly owns 8,051 shares of the company’s stock, valued at $831,668.30. The trade was a 25.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 7,696 shares of company stock valued at $794,853 in the last quarter. 1.31% of the stock is currently owned by corporate insiders.

Innospec declared that its board has initiated a share repurchase plan on Monday, March 10th that allows the company to buyback $50.00 million in shares. This buyback authorization allows the specialty chemicals company to repurchase up to 2% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board of directors believes its stock is undervalued.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.